by Kausalya Murthy | Jul 17, 2018 | Science |
Last week, our blog featured a recap of the first of two C. elegans topic meetings – CE Neuro 2018 – that some members of Perlara’s worm team attended last month. In this post, Hillary and I share our experiences at the CE Aging 2018 conference. Also...
by Feba Sam | Jul 10, 2018 | Science |
At Perlara, we work to find therapeutics for rare genetic diseases. We develop and use immunoassays, phase contrast imaging, as well as enzymatic assays, in order to screen thousands of compounds and obtain hits from cell readouts to complement our model organism...
by Sangeetha Iyer | Jul 9, 2018 | Science |
Perlara’s worm team recently attended two C. elegans neuroscience conferences – CE Neuro 2018 & CE Aging 2018 – both held at the University of Wisconsin, Madison. This post recaps Zach and my time at the CE Neuro 2018 conference, which focused on...
by Ethan Perlstein | Jun 4, 2018 | Organic Intelligence, Science |
What is the role of OI in drug discovery? Organic Intelligence (OI) is the collective brainpower and high emotional quotient of scientists and rare disease advocates teaming up to use the PerlArk™ Platform of model organisms, lab automation and computation for a new...
by Aras Rezvanian | May 23, 2018 | Science |
One of the rare genetic disorders that we at Perlara have been working on is Mucolipidosis type IV (MLIV) – one of the Mucolipidosis group of inherited lysosomal storage disorders. For background on MLIV, and to learn more about our work in optimizing a MLIV drug...
by Zach Parton | May 17, 2018 | Science |
In 2016, Perlara and Wylder Nation launched a PerlQuest to find a cure for Niemann-Pick Type A (NPA). We have also been developing simple organism disease models for Niemann-Pick Type C (NPC) as a part of our research collaboration with Novartis. An interesting...
